Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1721 Views
Dr Veena Aggarwal, Consultant Womens’ Health, CMD and Editor-in-Chief, IJCP Group & Medtalks Trustee, Dr KK’s Heart Care Foundation of India 18 December 2022
The US FDA has cautioned about the risk of severe hypocalcemia with the use of denosumab in patients with advanced kidney disease on dialysis in a drug safety communication. It has warned about serious adverse outcomes, necessitating hospitalization including death. The Agency is currently investigating the occurrence of this potentially life-threatening adverse effect in dialysis patients.1
Clinicians should therefore consider the risks of hypocalcemia, it says, when using denosumab in patients on dialysis and ensure adequate calcium and vitamin D supplementation. These patients should be frequently monitored for serum calcium to reduce the chances of hypocalcemia or minimize the severity. They should also warn their patients about the potential risks.
The FDA has also cautioned patients on dialysis to be aware of the symptoms of hypocalcemia such as unusual tingling or numbness in the hands, arms, legs, or feet; painful muscle spasms or cramps; difficulty breathing due to spasm of the larynx or lungs; vomiting; seizures or irregular heart rhythm. It also advises patients to not discontinue the drug on their own. Instead, they should consult their physician without any delay.
Denosumab, a monoclonal antibody, was approved for treatment of osteoporosis in postmenopausal women at risk for fracture in June 2010. The approval was further extended to include men with osteoporosis, steroid-induced osteoporosis, women on aromatase inhibitors for breast cancer and men taking androgen deprivation therapy for prostate cancer.
Reference
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Detecting Intra-abdominal Adhesions in Women with Repeated C-sections..
Maintaining Liver Health to Optimize Glycemic Outcomes in Early Type 2.....
Antibiotic Prescribing Practices for Pediatric Acute Otitis Media..
Hidden Hazard of Indoor Pollution in COPD..
Recognizing Pitfalls of Point-of-Care Lung Ultrasound..
{{Article_Title}}..
Bombay HC Questions Denial of Motherhood to Woman with Intellectual Disability..
HMPV Outbreak in India: Health Minister Warns of Similar Symptoms to COVID-19, States Prepare Special ICU Wards..
Maharashtra Medical Education Minister Warns Children and Elderly to Stay Alert amid HMPV Cases..
Medical Negligence in Rewa: Surgical Needle Left inside Woman's Abdomen for Two Years..
HMPV in India: Seven Cases Reported across Four States..